SEC Form 4 research
| Issuer | Chemomab Therapeutics Ltd. |
|---|---|
| Tickers | CMMB, ANCN |
| Reporting owners | 41 |
| Officers and directors | 0 |
| Last public filing | 2026-09-02 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-01 | 2026-08-28 | Cohen Neil Harris | S | 1,000 | $2.8 | Not reported |
| 2026-09-01 | 2026-08-27 | Cohen Neil Harris | S | 1,304 | $2.85 | Not reported |
| 2026-09-01 | 2026-03-16 | Cohen Neil Harris | A | 5,172 | $0 | Not reported |
| 2026-09-01 | 2025-03-16 | Cohen Neil Harris | A | 3,821 | $0 | Not reported |
| 2026-09-01 | 2024-03-18 | Cohen Neil Harris | A | 2,520 | $0 | Not reported |
| 2026-09-01 | 2023-03-21 | Cohen Neil Harris | A | 1,714 | $0 | Not reported |
| 2026-09-01 | 2022-03-07 | Cohen Neil Harris | A | 1,705 | $0 | Not reported |
| 2026-09-01 | 2021-04-19 | Cohen Neil Harris | A | 2,971 | $0 | Not reported |
| 2026-09-01 | 2020-07-16 | Cohen Neil Harris | A | 172 | $0 | Not reported |
No directory officers or directors published yet.
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.